Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06984640 · ClinicalTrials.gov registry record · NA
Curcumin Supplementation for the Improvement of Diabetes-related Outcomes
A NA study of Over Age 60 and Prediabetes or Overweight, sponsored by Oklahoma State University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT06984640 is a NA study of Over Age 60 and Prediabetes or Overweight that has completed, run by Oklahoma State University. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06984640, a NA study of Over Age 60 and Prediabetes or Overweight, has completed, sponsored by Oklahoma State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn about, test, and compare health outcomes of curcumin supplementation (400 mg). Two primary hypotheses are: 1. Curcumin supplementation will improve glycemic control in older adults with pre-diabetic conditions over a 12-week period. \* Rationale: Curcumin has been shown to enhance insulin sensitivity, reduce fasting blood glucose, and lower HbA1c levels in preclinical and clinical studies. This hypothesis will be tested by measuring changes in fasting glucose, insulin levels, and diabetic biomarkers from baseline (Week 0) to Week 12. 2. Curcumin supplementation will beneficially alter gut microbiota composition and diversity, which is associated with improved metabolic outcomes in older adults with pre-diabetes. * Rationale: Curcumin is known to possess prebiotic-like properties and can influence gut microbial populations. By analyzing stool samples using metagenomic sequencing, this hypothesis will evaluate whether curcumin intake leads to increased abundance of beneficial bacteria (e.g., Akkermansia, Faecalibacterium) and decreased pathogenic taxa, alongside improved metabolic markers.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Curcumin
Study Locations (1)
Oklahoma
- Laboratory for Applied Nutrition and Exercise Science (LANES) - Stillwater
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2023-03-16 |
| Est. Completion | 2025-02-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06984640
The ClinicalTrials.gov registry entry for NCT06984640 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oklahoma State University, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Over Age 60 appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06984640 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06984640 about?
NCT06984640 is a clinical study titled "Curcumin Supplementation for the Improvement of Diabetes-related Outcomes". The goal of this clinical trial is to learn about, test, and compare health outcomes of curcumin supplementation (400 mg). Two primary hypotheses are: 1. Curcumin supplementation will improve glycemic control in older adults with pre-diabetic conditions over a 12-week period. \* Rationale: Curc...
What is the current status of trial NCT06984640?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2023-03-16. Estimated completion is 2025-02-13.
What conditions does trial NCT06984640 study?
This clinical trial studies the following conditions: Over Age 60, Prediabetes or Overweight.
What interventions are being tested in trial NCT06984640?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Curcumin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06984640?
This trial is sponsored by Oklahoma State University, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06984640 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.